[go: up one dir, main page]

PE20010481A1 - Derivados de la octahidro-1h-pirido[1,2-a]pirazina 2,7-sustituida como ligandos para receptores de la serotonina - Google Patents

Derivados de la octahidro-1h-pirido[1,2-a]pirazina 2,7-sustituida como ligandos para receptores de la serotonina

Info

Publication number
PE20010481A1
PE20010481A1 PE2000000776A PE0007762000A PE20010481A1 PE 20010481 A1 PE20010481 A1 PE 20010481A1 PE 2000000776 A PE2000000776 A PE 2000000776A PE 0007762000 A PE0007762000 A PE 0007762000A PE 20010481 A1 PE20010481 A1 PE 20010481A1
Authority
PE
Peru
Prior art keywords
pyrid
octahydro
methyl
derivatives
substituted
Prior art date
Application number
PE2000000776A
Other languages
English (en)
Inventor
Mark Allen Sanner
Kishor Amratlal Desai
Anton Franz Josef Fliri
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20010481A1 publication Critical patent/PE20010481A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE AL USO DE DERIVADOS DE 2,7-SUSTITUIDO OCTAHIDRO-1H-PIRIDO[1,2-a]PIRAZINAS DE FORMULA I, DONDE Ar ES FENILO, NAFTILO, BENZOXAZOLONILO, INDOLILO, INDOLONILO, ENTRE OTROS; Ar1 ES FENILO, PIRIDINILO, PIRIDAZINILO, ENTRE OTROS; A ES O, S, SO, SO2, ENTRE OTROS; n ES 0-2; R, R1, R2 SON H, ALQUILO C1-C6; R3 Y R4 SON H, METILO, ETILO, n-PROPILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS (7S,9aS)-7-((3-METIL-FENOXI)METIL-2-(5-FLUOROPIRIMIDIN-2-IL)-2,3,4,6,7,8,9,9a-OCTAHIDRO-1H-PIRIDO[1,2-a]PIRAZINA, (7S,9aS)-7-(3-CARBOMETOXI-FENOXI)METIL-2-(5-FLUOROPIRIMIDIN-2-IL)-2,3,4,7,8,9,9a-OCTAHIDRO-1H-PIRIDO[1,2-a]PIRAZINA, ENTRE OTROS. EL COMPUESTO I ES UN LIGANDO DEL RECEPTOR DE SEROTONINA 5HT1A Y ES UN LIGANDO DE RECEPTORES DE LA DOPAMINA Y PUEDE SER UTIL PARA EL TRATAMIENTO DE LA ANSIEDAD, DEPRESION, DISTIMIA, TRASTORNO DEPRESIVO MAYOR, TRASTORNO DE PANICO, TRASTORNO OBSESIVO COMPULSIVO
PE2000000776A 1999-08-05 2000-08-03 Derivados de la octahidro-1h-pirido[1,2-a]pirazina 2,7-sustituida como ligandos para receptores de la serotonina PE20010481A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/368,984 US6231833B1 (en) 1999-08-05 1999-08-05 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors

Publications (1)

Publication Number Publication Date
PE20010481A1 true PE20010481A1 (es) 2001-04-21

Family

ID=23453575

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000776A PE20010481A1 (es) 1999-08-05 2000-08-03 Derivados de la octahidro-1h-pirido[1,2-a]pirazina 2,7-sustituida como ligandos para receptores de la serotonina

Country Status (11)

Country Link
US (4) US6231833B1 (es)
EP (1) EP1074257A1 (es)
JP (2) JP2001064178A (es)
KR (1) KR20010021215A (es)
AU (1) AU775093B2 (es)
CA (1) CA2314867A1 (es)
CO (1) CO5180647A1 (es)
HU (1) HUP0003118A3 (es)
IL (1) IL137554A0 (es)
NZ (2) NZ506154A (es)
PE (1) PE20010481A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
EP1177792A3 (en) * 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamine D4 Ligands for the treatment of novelty-seeking disorders
US6670476B2 (en) * 2000-11-29 2003-12-30 Pfizer Inc. Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
CA2364211A1 (en) * 2000-12-05 2002-06-05 Phillip Branch Chappell Combination treatment for depression, anxiety and psychosis
US20040102455A1 (en) * 2001-01-30 2004-05-27 Burns Christopher John Method of inhibiting kinases
FR2827288B1 (fr) * 2001-07-12 2003-10-31 Servier Lab Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2002950217A0 (en) 2002-07-16 2002-09-12 Prana Biotechnology Limited 8- Hydroxy Quinoline Derivatives
US6855014B2 (en) * 2002-07-19 2005-02-15 Yamaha Marine Kabushiki Kaisha Control for watercraft propulsion system
US7694151B1 (en) * 2003-11-20 2010-04-06 Johnson Richard C Architecture, system, and method for operating on encrypted and/or hidden information
WO2005121796A2 (en) * 2004-05-07 2005-12-22 The Regents Of The University Of California Method for detecting alzheimer’s disease and other forms of dementia, and measuring their progression
MXPA06015267A (es) * 2004-06-22 2007-03-15 Pfizer Prod Inc Antagonistas diazabiciclicos del receptor histamina-3.
TW200801005A (en) * 2005-08-15 2008-01-01 Astrazeneca Ab Acetylenic piperazines as metabotropic glutamate receptor antagonists
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
AU2009283195A1 (en) * 2008-08-18 2010-02-25 Yale University MIF modulators
CN108409728B (zh) * 2017-02-09 2020-11-24 广东东阳光药业有限公司 苯基八氢-1H-吡啶并[1,2-a]吡嗪衍生物及其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX19222A (es) 1989-01-23 1993-12-01 Pfizer Agentes ansioliticos bis-aza-biciclicos
WO1992000075A1 (en) 1990-06-29 1992-01-09 Pfizer Inc. Pyridopyrazine derivatives for treating substance abuse and addiction
US5157034A (en) 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
MX9201991A (es) 1991-05-02 1992-11-01 Jonh Wyeth & Brother Limited Derivados de piperazina y procedimiento para su preparacion.
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
MX9702350A (es) 1994-09-30 1997-06-28 Pfizer Derivados 2,7-sustituidos de octahidro-1h-pirido (1,2-a) pirazina.
US5602128A (en) 1994-12-02 1997-02-11 American Home Products Corporation N-heterocycloalkyl carboxamides as serotonergic agents
US5741789A (en) * 1995-01-17 1998-04-21 Eli Lilly And Company Compounds having effects on serotonin-related systems
AU4547796A (en) 1995-02-03 1996-08-21 Sankyo Company Limited Hexahydropyrazinoquinoline derivatives
AU6542896A (en) 1995-07-11 1997-02-10 Merck & Co., Inc. A triazolylmethyl-indole ethylamine bisulfate salt
PT759299E (pt) 1995-08-16 2000-09-29 Lilly Co Eli Potenciacao da resposta de serotonina
GB9517381D0 (en) 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
AR004229A1 (es) 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
KR20010042552A (ko) 1998-04-09 2001-05-25 피터 기딩스 파록세틴 말레에이트

Also Published As

Publication number Publication date
CO5180647A1 (es) 2002-07-30
JP2001064178A (ja) 2001-03-13
US20040214830A1 (en) 2004-10-28
JP2004010619A (ja) 2004-01-15
US20030055061A1 (en) 2003-03-20
US6231833B1 (en) 2001-05-15
NZ506154A (en) 2002-03-01
HU0003118D0 (en) 2000-10-28
NZ515882A (en) 2004-12-24
AU775093B2 (en) 2004-07-15
IL137554A0 (en) 2001-07-24
HUP0003118A2 (hu) 2001-04-28
EP1074257A1 (en) 2001-02-07
US7220753B2 (en) 2007-05-22
KR20010021215A (ko) 2001-03-15
US20020132811A1 (en) 2002-09-19
AU4897600A (en) 2001-02-08
CA2314867A1 (en) 2001-02-05
HUP0003118A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
PE20010481A1 (es) Derivados de la octahidro-1h-pirido[1,2-a]pirazina 2,7-sustituida como ligandos para receptores de la serotonina
PE20020911A1 (es) Derivados de indol como agonistas de 5ht2
PE20030847A1 (es) Aza-arilpiperazinas como ligandos del receptor 5ht2
PE20030431A1 (es) DERIVADOS QUINUCLIDINAS COMO AGONISTAS DEL RECEPTOR NICOTINICO DE LA ACETILCOLINA TIPO a7
PE20020721A1 (es) Derivados de quinuclidina como agentes antimuscarinicos m3
PE20030848A1 (es) Compuestos de espiropiperidina n-sustituidos como ligandos para el receptor orl-1
AR035774A1 (es) Derivados benzimidazol y piridilimidazol, un procedimiento para su preparacion, composiciones farmaceuticas y paquetes que los comprenden, el uso de dichos compuestos solos o en combinacion para la manufactura de medicamentos como ligandos para gabaa, y metodo de tratamiento
PE20070002A1 (es) Compuestos derivados de heteroaril como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo i
PE20010052A1 (es) Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht
PE20010741A1 (es) Derivados de piperazina como antagonistas de taquicininas
UY28150A1 (es) Agentes terapeuticos
PE20010575A1 (es) Derivados de indol y su uso como ligandos del receptor 5ht2
PE20000467A1 (es) Derivado de indol util como inhibidor de serotonina
PE20050896A1 (es) Intermediarios de quinolina como inhibidores de tirosina quinasas de receptores y la sintesis de los mismos
AR027059A1 (es) Bases de mannich indolicas, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su uso para la preparacion de medicamentos
CS220320B2 (en) Method of producing new n-/phenylhydroxyalkyl/aminoalkylheterocycles
KR950701323A (ko) 1-피페라지노-1,2-디히드로인덴 유도체(1-Piperazino-1,2-dihydroindene Derivatives)
ATE247639T1 (de) Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
BR0309463A (pt) Derivados de 1,2,3,4,7,8-hexaidro-6h-[1,4]diazepino[6,7,1-ij]quinolina como agentes antipsicóticos e antiobesidade
AR056613A1 (es) Compuestos derivados de lapachona, su preparacion y metodos de uso de los mismos para el tratamiento o prevencion de trastornos proliferativos celulares y composiciones farmaceuticas que los contienen
RU2368608C2 (ru) Производные пиперидина в качестве модуляторов хемокинового рецептора ccr5
DE60014339T8 (de) Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
PE74899A1 (es) Derivados de ergolina
ES2154470T3 (es) Derivados de tetrahidroisoquinolina y su uso farmaceutico.
AR044662A1 (es) Compuestos de azetidina

Legal Events

Date Code Title Description
FC Refusal